Back to Journals » OncoTargets and Therapy » Volume 13

lncRNA CRNDE is Upregulated in Glioblastoma Multiforme and Facilitates Cancer Progression Through Targeting miR-337-3p and ELMOD2 Axis [Retraction]

Authors Gao J, Chen Q, Zhao Y, Hou R

Received 7 December 2020

Accepted for publication 7 December 2020

Published 10 December 2020 Volume 2020:13 Pages 12721—12722

DOI https://doi.org/10.2147/OTT.S296124

Download Article [PDF] 

Gao J, Chen Q, Zhao Y, Hou R. Onco Targets Ther. 2020;13:9225–9234.


At the authors request, the Editor and Publisher of OncoTargets and Therapy wish to retract the published article.


Following a review of their original data the authors found an error with the data input and statistical analysis for the expression of the CRNDE in glioblastoma multiforme (GBM) shown in Figure 1C. The cells were treated correctly, however the original data was mistakenly input and mis-calculated resulting in the incorrect values for the Relative CRNDE expression described in Figure 1C. The data no longer supports the finding that a significant difference was found when comparing relative CRNDE expression of GBM (U87, U251 and LN229) cells to NHA (Normal Human Astrocytes) cells. The authors require further investigation of this data and in the interests of scientific integrity wish to retract the published  article.


The Editor has also determined the findings are no longer valid and has agreed with the authors request for the paper to be retracted.


Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.


The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]